Report cover image

Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Research Report 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 127 Pages
SKU # APRC20542795

Description

Summary

According to APO Research, The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Transient Receptor Potential Cation Channel Subfamily V Member 1 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Transient Receptor Potential Cation Channel Subfamily V Member 1 include Amgen Inc, Vitality Biopharma Inc, Toray Industries Inc, Sylentis SAU, Pila Pharma AB, Neurim Pharmaceuticals Ltd, Medifron DBT Co Ltd, Kyowa Hakko Kirin Co Ltd and Grunenthal GmbH, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transient Receptor Potential Cation Channel Subfamily V Member 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transient Receptor Potential Cation Channel Subfamily V Member 1.
The Transient Receptor Potential Cation Channel Subfamily V Member 1 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Company

Amgen Inc
Vitality Biopharma Inc
Toray Industries Inc
Sylentis SAU
Pila Pharma AB
Neurim Pharmaceuticals Ltd
Medifron DBT Co Ltd
Kyowa Hakko Kirin Co Ltd
Grunenthal GmbH
Flex Pharma Inc
DoNatur GmbH
Daewoong Pharmaceutical Co Ltd
Centrexion Therapeutics Corp
BCN Peptides SA
Amorepacific Corp
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type

DD-04107
CMX-020
CA-016
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application

Abdominal Pain
Muscle Spasm
Immunology
Pruritus
Ophthalmology
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application

Abdominal Pain
Muscle Spasm
Immunology
Pruritus
Ophthalmology
Others
Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transient Receptor Potential Cation Channel Subfamily V Member 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transient Receptor Potential Cation Channel Subfamily V Member 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

127 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 DD-04107
2.2.3 CMX-020
2.2.4 CA-016
2.2.5 Others
2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Abdominal Pain
2.3.3 Muscle Spasm
2.3.4 Immunology
2.3.5 Pruritus
2.3.6 Ophthalmology
2.3.7 Others
2.4 Assumptions and Limitations
3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Type
3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Type (2020-2025)
3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2026-2031)
4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Application
4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Application (2020-2025)
4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Perspective (2020-2031)
5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Trends by Region
5.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Region (2020-2025)
5.2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Region (2026-2031)
5.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
5.3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
5.3.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
5.3.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
5.3.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue
6.1.1 Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue (2020-2025)
6.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2020-2025)
6.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1 Head Office and Area Served
6.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players, Product Type & Application
6.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Manufacturers Established Date
6.6 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2020-2031)
7.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025)
7.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2020-2031)
8.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025)
8.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2020-2031)
9.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025)
9.4 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2020-2031)
10.2 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025)
10.4 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2020-2031)
11.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025)
11.4 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Amgen Inc
12.1.1 Amgen Inc Company Information
12.1.2 Amgen Inc Business Overview
12.1.3 Amgen Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.1.5 Amgen Inc Recent Developments
12.2 Vitality Biopharma Inc
12.2.1 Vitality Biopharma Inc Company Information
12.2.2 Vitality Biopharma Inc Business Overview
12.2.3 Vitality Biopharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.2.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.2.5 Vitality Biopharma Inc Recent Developments
12.3 Toray Industries Inc
12.3.1 Toray Industries Inc Company Information
12.3.2 Toray Industries Inc Business Overview
12.3.3 Toray Industries Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.3.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.3.5 Toray Industries Inc Recent Developments
12.4 Sylentis SAU
12.4.1 Sylentis SAU Company Information
12.4.2 Sylentis SAU Business Overview
12.4.3 Sylentis SAU Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.4.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.4.5 Sylentis SAU Recent Developments
12.5 Pila Pharma AB
12.5.1 Pila Pharma AB Company Information
12.5.2 Pila Pharma AB Business Overview
12.5.3 Pila Pharma AB Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.5.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.5.5 Pila Pharma AB Recent Developments
12.6 Neurim Pharmaceuticals Ltd
12.6.1 Neurim Pharmaceuticals Ltd Company Information
12.6.2 Neurim Pharmaceuticals Ltd Business Overview
12.6.3 Neurim Pharmaceuticals Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.6.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.6.5 Neurim Pharmaceuticals Ltd Recent Developments
12.7 Medifron DBT Co Ltd
12.7.1 Medifron DBT Co Ltd Company Information
12.7.2 Medifron DBT Co Ltd Business Overview
12.7.3 Medifron DBT Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.7.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.7.5 Medifron DBT Co Ltd Recent Developments
12.8 Kyowa Hakko Kirin Co Ltd
12.8.1 Kyowa Hakko Kirin Co Ltd Company Information
12.8.2 Kyowa Hakko Kirin Co Ltd Business Overview
12.8.3 Kyowa Hakko Kirin Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.8.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.8.5 Kyowa Hakko Kirin Co Ltd Recent Developments
12.9 Grunenthal GmbH
12.9.1 Grunenthal GmbH Company Information
12.9.2 Grunenthal GmbH Business Overview
12.9.3 Grunenthal GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.9.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.9.5 Grunenthal GmbH Recent Developments
12.10 Flex Pharma Inc
12.10.1 Flex Pharma Inc Company Information
12.10.2 Flex Pharma Inc Business Overview
12.10.3 Flex Pharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.10.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.10.5 Flex Pharma Inc Recent Developments
12.11 DoNatur GmbH
12.11.1 DoNatur GmbH Company Information
12.11.2 DoNatur GmbH Business Overview
12.11.3 DoNatur GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.11.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.11.5 DoNatur GmbH Recent Developments
12.12 Daewoong Pharmaceutical Co Ltd
12.12.1 Daewoong Pharmaceutical Co Ltd Company Information
12.12.2 Daewoong Pharmaceutical Co Ltd Business Overview
12.12.3 Daewoong Pharmaceutical Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.12.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.12.5 Daewoong Pharmaceutical Co Ltd Recent Developments
12.13 Centrexion Therapeutics Corp
12.13.1 Centrexion Therapeutics Corp Company Information
12.13.2 Centrexion Therapeutics Corp Business Overview
12.13.3 Centrexion Therapeutics Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.13.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.13.5 Centrexion Therapeutics Corp Recent Developments
12.14 BCN Peptides SA
12.14.1 BCN Peptides SA Company Information
12.14.2 BCN Peptides SA Business Overview
12.14.3 BCN Peptides SA Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.14.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.14.5 BCN Peptides SA Recent Developments
12.15 Amorepacific Corp
12.15.1 Amorepacific Corp Company Information
12.15.2 Amorepacific Corp Business Overview
12.15.3 Amorepacific Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025)
12.15.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
12.15.5 Amorepacific Corp Recent Developments
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2020-2025) & (US$ Million)
Table 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2020-2025)
Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2026-2031)
Table 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2020-2025) & (US$ Million)
Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2020-2025)
Table 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2026-2031)
Table 13. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2020-2025)
Table 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2026-2031)
Table 18. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
Table 19. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers
Table 20. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges
Table 21. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
Table 22. Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue (US$ Million) & (2020-2025)
Table 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2020-2025)
Table 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Players Ranking, 2023 VS 2024 VS 2025
Table 25. Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1, Headquarters and Area Served
Table 26. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025) & (US$ Million)
Table 32. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031) & (US$ Million)
Table 33. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 34. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025) & (US$ Million)
Table 35. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2020-2025) & (US$ Million)
Table 38. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031) & (US$ Million)
Table 39. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 40. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025) & (US$ Million)
Table 41. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031) & (US$ Million)
Table 42. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2026-2031) & (US$ Million)
Table 45. Amgen Inc Company Information
Table 46. Amgen Inc Business Overview
Table 47. Amgen Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 48. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 49. Amgen Inc Recent Developments
Table 50. Vitality Biopharma Inc Company Information
Table 51. Vitality Biopharma Inc Business Overview
Table 52. Vitality Biopharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 53. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 54. Vitality Biopharma Inc Recent Developments
Table 55. Toray Industries Inc Company Information
Table 56. Toray Industries Inc Business Overview
Table 57. Toray Industries Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 58. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 59. Toray Industries Inc Recent Developments
Table 60. Sylentis SAU Company Information
Table 61. Sylentis SAU Business Overview
Table 62. Sylentis SAU Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 63. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 64. Sylentis SAU Recent Developments
Table 65. Pila Pharma AB Company Information
Table 66. Pila Pharma AB Business Overview
Table 67. Pila Pharma AB Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 68. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 69. Pila Pharma AB Recent Developments
Table 70. Neurim Pharmaceuticals Ltd Company Information
Table 71. Neurim Pharmaceuticals Ltd Business Overview
Table 72. Neurim Pharmaceuticals Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 73. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 74. Neurim Pharmaceuticals Ltd Recent Developments
Table 75. Medifron DBT Co Ltd Company Information
Table 76. Medifron DBT Co Ltd Business Overview
Table 77. Medifron DBT Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 78. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 79. Medifron DBT Co Ltd Recent Developments
Table 80. Kyowa Hakko Kirin Co Ltd Company Information
Table 81. Kyowa Hakko Kirin Co Ltd Business Overview
Table 82. Kyowa Hakko Kirin Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 83. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 84. Kyowa Hakko Kirin Co Ltd Recent Developments
Table 85. Grunenthal GmbH Company Information
Table 86. Grunenthal GmbH Business Overview
Table 87. Grunenthal GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 88. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 89. Grunenthal GmbH Recent Developments
Table 90. Flex Pharma Inc Company Information
Table 91. Flex Pharma Inc Business Overview
Table 92. Flex Pharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 93. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 94. Flex Pharma Inc Recent Developments
Table 95. DoNatur GmbH Company Information
Table 96. DoNatur GmbH Business Overview
Table 97. DoNatur GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 98. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 99. DoNatur GmbH Recent Developments
Table 100. Daewoong Pharmaceutical Co Ltd Company Information
Table 101. Daewoong Pharmaceutical Co Ltd Business Overview
Table 102. Daewoong Pharmaceutical Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 103. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 104. Daewoong Pharmaceutical Co Ltd Recent Developments
Table 105. Centrexion Therapeutics Corp Company Information
Table 106. Centrexion Therapeutics Corp Business Overview
Table 107. Centrexion Therapeutics Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 108. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 109. Centrexion Therapeutics Corp Recent Developments
Table 110. BCN Peptides SA Company Information
Table 111. BCN Peptides SA Business Overview
Table 112. BCN Peptides SA Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 113. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 114. BCN Peptides SA Recent Developments
Table 115. Amorepacific Corp Company Information
Table 116. Amorepacific Corp Business Overview
Table 117. Amorepacific Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2020-2025) & (US$ Million)
Table 118. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
Table 119. Amorepacific Corp Recent Developments
Table 120. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Image
Figure 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type: 2024 VS 2031
Figure 7. DD-04107 Product
Figure 8. CMX-020 Product
Figure 9. CA-016 Product
Figure 10. Others Product
Figure 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2025-2031) & (US$ Million)
Figure 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application: 2024 VS 2031
Figure 13. Abdominal Pain Product
Figure 14. Muscle Spasm Product
Figure 15. Immunology Product
Figure 16. Pruritus Product
Figure 17. Ophthalmology Product
Figure 18. Others Product
Figure 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region: 2024 VS 2031
Figure 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players in 2024
Figure 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Manufacturers Established Date
Figure 24. Global Top 5 and 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Share by Revenue in 2024
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2020-2031)
Figure 28. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2020-2031)
Figure 31. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2020-2031)
Figure 33. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Netherlands Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2020-2031)
Figure 43. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2020-2031)
Figure 48. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. China Taiwan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2020-2031)
Figure 53. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Colombia Transient Receptor Potent
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.